Caixin
Jan 17, 2019 08:07 PM
BUSINESS & TECH

Pharma Firms Allowed to Set Their Own Prices for Cancer Drug in Central Province

China had 4.29 million new cases of cancer in 2015 and 2.81 million deaths, according to figures from the National Cancer Center. Photo: VCG
China had 4.29 million new cases of cancer in 2015 and 2.81 million deaths, according to figures from the National Cancer Center. Photo: VCG

A provincial government will allow three pharmaceutical companies to continue setting their own prices for a high-profile cancer drug in a rebuke of central health authorities’ efforts to roll out a centralized procurement plan.

China’s State Medical Insurance Administration and the National Health Commission released a regulation in August requiring cancer-drug manufacturers to bid for the right to supply hospitals across the country in an attempt to put downward pressure on prices.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
GALLERY
Copyright © 2017 Caixin Global Limited. All Rights Reserved.